Cancer Rop Co. Ltd. (180400) — Capital Reinvestment Ratio
Cancer Rop Co. Ltd. (180400) has a Capital Reinvestment Ratio of 2.01x as of December 2022, meaning it reinvests 2% of its operating cash flow (₩865.55 Million) in capital expenditures (₩1.74 Billion). Check Cancer Rop Co. Ltd. tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Cancer Rop Co. Ltd. Capital Reinvestment Ratio (2014–2022)
This chart tracks Cancer Rop Co. Ltd.'s Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see 180400 operating cash flow.
Annual Capital Reinvestment Ratio for Cancer Rop Co. Ltd. (2014–2022)
Year-by-year Capital Reinvestment Ratio for Cancer Rop Co. Ltd. from 2014 to 2022. See Cancer Rop Co. Ltd. free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 2.01x | ₩865.55 Million | ₩1.74 Billion | ▲ +397.1% |
| 2014 | 0.40x | ₩783.83 Million | ₩316.72 Million | — |